Anthony C. Lane

1.0k total citations
17 papers, 871 citations indexed

About

Anthony C. Lane is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Anthony C. Lane has authored 17 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Anthony C. Lane's work include Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Neuropeptides and Animal Physiology (5 papers). Anthony C. Lane is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Neuropeptides and Animal Physiology (5 papers). Anthony C. Lane collaborates with scholars based in Netherlands and United Kingdom. Anthony C. Lane's co-authors include Michael J. Rance, Colin F. C. Smith, John A.H. Lord, B.K. Handa, Barry A. Morgan, Alan G. Roach, John C. Doxey, D.S. Walter, I.F. Tulloch and David Howlett and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Anthony C. Lane

17 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony C. Lane Netherlands 11 679 614 203 67 66 17 871
Marie‐Claude Burgevin France 14 492 0.7× 464 0.8× 105 0.5× 34 0.5× 64 1.0× 24 750
C. Malgouris France 15 660 1.0× 455 0.7× 83 0.4× 22 0.3× 85 1.3× 25 947
R.M. Hagan United Kingdom 18 916 1.3× 757 1.2× 255 1.3× 142 2.1× 79 1.2× 36 1.1k
George A. Matwyshyn United States 17 474 0.7× 335 0.5× 315 1.6× 53 0.8× 21 0.3× 43 710
V.R. Olgiati Italy 14 472 0.7× 276 0.4× 237 1.2× 80 1.2× 96 1.5× 29 841
E. Giraldo Italy 18 834 1.2× 1.0k 1.6× 136 0.7× 51 0.8× 83 1.3× 27 1.3k
L Ahtee Finland 16 455 0.7× 309 0.5× 163 0.8× 55 0.8× 16 0.2× 48 680
John E. Folk United States 18 683 1.0× 535 0.9× 293 1.4× 35 0.5× 90 1.4× 33 1.1k
C H Li United States 13 1.0k 1.5× 904 1.5× 426 2.1× 107 1.6× 56 0.8× 22 1.4k
Chester J. Siok United States 15 407 0.6× 417 0.7× 146 0.7× 40 0.6× 33 0.5× 19 868

Countries citing papers authored by Anthony C. Lane

Since Specialization
Citations

This map shows the geographic impact of Anthony C. Lane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony C. Lane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony C. Lane more than expected).

Fields of papers citing papers by Anthony C. Lane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony C. Lane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony C. Lane. The network helps show where Anthony C. Lane may publish in the future.

Co-authorship network of co-authors of Anthony C. Lane

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony C. Lane. A scholar is included among the top collaborators of Anthony C. Lane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony C. Lane. Anthony C. Lane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chapleo, Christopher B., Anthony C. Lane, Malcolm Myers, et al.. (1988). Indoline analogs of idazoxan: potent .alpha.2-antagonists and .alpha.1-agonists. Journal of Medicinal Chemistry. 31(5). 944–948. 30 indexed citations
2.
Lane, Anthony C., et al.. (1988). Determination of idazoxan in plasma by radioreceptor assay. Journal of Pharmaceutical and Biomedical Analysis. 6(6-8). 787–792. 3 indexed citations
3.
Welbourn, Anthony P., Christopher B. Chapleo, Anthony C. Lane, et al.. (1987). ChemInform Abstract: α‐Adrenoreceptor Reagents. Part 4. Resolution of Some Potent Selective Prejunctional α2‐Adrenoreceptor Antagonists.. ChemInform. 18(11). 5 indexed citations
4.
Welbourn, Anthony P., Christopher B. Chapleo, Anthony C. Lane, et al.. (1986). .alpha.-Adrenoreceptor reagents. 4. Resolution of some potent selective prejunctional .alpha.2-adrenoreceptor antagonists. Journal of Medicinal Chemistry. 29(10). 2000–2003. 29 indexed citations
5.
Lane, Anthony C., Gareth W. John, & M. E. Havler. (1986). A simple method for the isolation of islets of Langerhans from rat pancreas. Biochemical Society Transactions. 14(2). 322–323. 1 indexed citations
6.
Gadie, B., Anthony C. Lane, P. S. McCarthy, I.F. Tulloch, & D.S. Walter. (1984). 2‐Alkyl analogues of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central α2‐adrenoceptors in the rat. British Journal of Pharmacology. 83(3). 707–712. 12 indexed citations
7.
Walter, D.S., I. R. Flockhart, David Howlett, et al.. (1984). Effects of idazoxan on catecholamine systems in rat brain. Biochemical Pharmacology. 33(16). 2553–2557. 46 indexed citations
8.
Doxey, John C., et al.. (1984). Comparison of the ?-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn-Schmiedeberg s Archives of Pharmacology. 325(2). 136–144. 157 indexed citations
9.
Doxey, John C., B. Gadie, Anthony C. Lane, & I.F. Tulloch. (1983). Evidence for pharmacological similarity between α2,‐adrenoceptors in the vas deferens and central nervous system of the rat. British Journal of Pharmacology. 80(1). 155–161. 28 indexed citations
10.
Lane, Anthony C., David Howlett, & D.S. Walter. (1983). The effects of metal ions on the binding of a new α2-adrenoceptor antagonist radioligand (3H)-RX 781094 in rat cerebral cortex. Biochemical Pharmacology. 32(20). 3122–3125. 14 indexed citations
11.
KOBYLECKI, R. J., Robert W. Carling, John A.H. Lord, Colin F. C. Smith, & Anthony C. Lane. (1982). Common anionic receptor site hypothesis: its relevance to the antagonist action of naloxone. Journal of Medicinal Chemistry. 25(2). 116–120. 27 indexed citations
12.
KOBYLECKI, R. J., Anthony C. Lane, Colin F. C. Smith, et al.. (1982). N-methylnalorphine: definition of N-allyl conformation for antagonism at the opiate receptor. Journal of Medicinal Chemistry. 25(11). 1278–1280. 10 indexed citations
13.
Handa, B.K., Anthony C. Lane, John A.H. Lord, et al.. (1981). Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptors. European Journal of Pharmacology. 70(4). 531–540. 444 indexed citations
14.
Lane, Anthony C., Michael J. Rance, & D.S. Walter. (1977). Subcellular localisation of leucine-enkephalin-hydrolysing activity in rat brain. Nature. 269(5623). 75–76. 49 indexed citations
15.
McCoubrey, A, et al.. (1970). Inhibition of enzymes by alkylsalicylic acids. Journal of Pharmacy and Pharmacology. 22(5). 333–337. 4 indexed citations
16.
Lane, Anthony C., et al.. (1966). Preparation of formaldehyde by photochemical condensation of carbon monoxide and tritiated hydrogen, and the synthesis of a tritiated morphine derivative. Journal of Labelled Compounds. 2(3). 284–288. 5 indexed citations
17.
Lane, Anthony C., et al.. (1966). Inhibition of cholinesterases by complex derivatives of morphine. Biochemical Pharmacology. 15(1). 122–123. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026